Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. | World J Stem Cells | 2023 | 37342225 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects. | Int J Mol Sci | 2023 | 37298466 | PubTator, text mining | PubMed |
| Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells. | Int J Mol Sci | 2023 | 37298099 | PubTator, text mining | PubMed |
| Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review. | Cancers (Basel) | 2023 | 37296950 | PubTator, text mining | PubMed |
| Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. | Cancer Epidemiol Biomarkers Prev | 2023 | 37294695 | PubTator, text mining | PubMed |
| The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis. | Front Pharmacol | 2023 | 37274115 | PubTator, text mining | PubMed |
| PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. | Front Oncol | 2023 | 37260977 | PubTator, text mining | PubMed |
| Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. | Pharmaceutics | 2023 | 37242727 | PubTator, text mining | PubMed |
| Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey. | Molecules | 2023 | 37241719 | PubTator, text mining | PubMed |
| Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue Engineering. | Int J Mol Sci | 2023 | 37240176 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
| A prediction model identifying glycolysis signature as therapeutic target for psoriasis. | Front Immunol | 2023 | 37205116 | PubTator, text mining | PubMed |
| Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma. | J Gastrointest Oncol | 2023 | 37201096 | PubTator, text mining | PubMed |
| The influence of pyroptosis-related genes on the development of chronic obstructive pulmonary disease. | BMC Pulm Med | 2023 | 37194062 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia. | Cells | 2023 | 37190037 | PubTator, text mining | PubMed |
| Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach. | Int J Biol Macromol | 2023 | 37160174 | PubTator, text mining | PubMed |
| Thermal inkjet bioprinting drastically alters cell phenotype. | Biofabrication | 2023 | 37160133 | PubTator, text mining | PubMed |
| A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer. | Int J Mol Sci | 2023 | 37108377 | PubTator, text mining | PubMed |
| Advances in Natural Products from the Marine-Sponge-Associated Microorganisms with Antimicrobial Activity in the Last Decade. | Mar Drugs | 2023 | 37103375 | PubTator, text mining | PubMed |
| Recent advances and application value of circRNA in neuroblastoma. | Front Oncol | 2023 | 37091173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=9